Cannabotech Ltd. Logo

Cannabotech Ltd.

CNTC | TA

Overview

Corporate Details

ISIN(s):
IL0011769085
LEI:
Country:
Israel
Address:
3 Arik Einstein, 4659071 Herzliya
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cannabotech Ltd. is a biomedical company focused on the research, development, and commercialization of botanical medical solutions. The company's core strategy involves integrating the therapeutic properties of cannabinoids and functional mushrooms to create innovative healthcare products. Its pipeline includes preventative care solutions and treatments targeting various indications such as cancer, chronic pain, and inflammation. Cannabotech also develops personalized cannabinoid-based formulas, CBD-infused food supplements, and skincare products.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cannabotech Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-02-10 17:47
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2025-01-09 10:41
Regulatory News Service
Capital consolidation 10:1, There will be no trading in the company's shares on…
Hebrew (modern) 77.6 KB
2024-11-12 18:33
Regulatory News Service
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday…
Hebrew (modern) 158.8 KB
2024-10-01 10:13
Regulatory News Service
Suspension due to failure in publication of financial reports
Hebrew (modern) 79.6 KB
2024-09-29 17:58
Regulatory News Service
CANNABOTECH– Appointment of a Market Maker
Hebrew (modern) 151.8 KB
2024-09-23 19:44
Regulatory News Service
Failure in publishing financial reports-Notification
Hebrew (modern) 127.4 KB
2024-09-02 15:06
Regulatory News Service
Discontinuation of Market Making
Hebrew (modern) 92.1 KB
2022-01-11 15:43
Regulatory News Service
Opening of Trading on January 12 2022- CANNABOTECH W3
Hebrew (modern) 253.5 KB
2022-01-10 10:54
Regulatory News Service
Identifying Details of New Security-CANNABOTECH W3
Hebrew (modern) 174.6 KB
2021-09-13 19:45
Regulatory News Service
will not be added TA-Tech Elite Index
Hebrew (modern) 82.9 KB
2021-07-25 18:17
Regulatory News Service
Fast Track to TA-Tech Elite Index as on October 7th, 2021 at the end of the tra…
Hebrew (modern) 162.5 KB
2021-07-25 16:07
Regulatory News Service
Appointment of a Market Maker
Hebrew (modern) 210.0 KB
2021-07-21 18:34
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 244.6 KB
2021-06-15 16:11
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 155.0 KB

Automate Your Workflow. Get a real-time feed of all Cannabotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cannabotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN